Post-inflammatory hyperpigmentation, or PIH, is a darkened area of skin that remains after inflammation from a rash, eczema flare, insect bite, burn, or allergic reaction has subsided. Dermatologists generally recommend controlling the original inflammation, using broad-spectrum sunscreen every day, avoiding irritating “bleaching” remedies, and considering targeted treatments such as azelaic acid, retinoids, hydroquinone, or selected procedures. The American Academy of Dermatology notes that PIH is especially common and persistent in people with darker skin tones, making accurate diagnosis and gradual treatment important.
Post-Inflammatory Hyperpigmentation Treatment Recommendations
Dermatologists define post-inflammatory hyperpigmentation as excess pigment that develops after an inflammatory skin injury. The inflammation can stimulate melanocytes, the pigment-producing cells in the epidermis, causing them to produce and transfer more melanin. In some cases, inflammation also damages the epidermis and deposits pigment deeper in the dermis, where fading is slower.
PIH is a sequela rather than an active rash. Its common triggers include atopic dermatitis, contact dermatitis, acne, psoriasis, folliculitis, insect bites, burns, and reactions to cosmetic products. The American Academy of Dermatology emphasizes that darker skin is more prone to noticeable PIH and that irritation from treatment can create additional dark marks. This is why dermatologists usually treat both the underlying rash and the pigment rather than applying a strong lightening product immediately.
Epidermal and Dermal Pigment
Epidermal PIH is located closer to the skin surface and often appears brown or medium brown. It may respond more predictably to sunscreen and topical pigment-modulating treatments. Dermal PIH can look gray-brown or slate-colored because melanin has moved deeper into the skin. Dermatology references such as DermNet explain that deeper pigment commonly takes longer to fade and may respond incompletely to topical products.
Color alone cannot reliably identify the depth of pigment. A dermatologist may use a Wood lamp, dermatoscope, medical history, and examination of the original rash. Persistent, spreading, itchy, scaly, painful, or changing discoloration may indicate ongoing dermatitis, infection, a medication reaction, or another diagnosis rather than simple PIH.
PIH Versus Persistent Inflammation
A flat brown mark that is no longer itchy, scaly, swollen, or tender is more consistent with residual PIH. Continued redness, itch, scale, cracking, or raised texture suggests that the inflammatory condition may still be active. Treating pigment while the rash continues can worsen irritation and delay recovery.
For example, a person with eczema may mistake ongoing low-level inflammation for discoloration. A dermatologist may first recommend a moisturizer and a short, appropriate anti-inflammatory regimen, then address remaining pigment after the skin barrier has recovered. This sequence is a practical bridge between rash control and pigment correction.
Sun Protection for Post-Inflammatory Hyperpigmentation
Daily photoprotection is the foundation of PIH management because ultraviolet radiation can stimulate melanin and darken existing marks. Visible light can also worsen pigmentation, particularly in medium-to-deep skin tones. Dermatologists commonly recommend a broad-spectrum sunscreen with SPF 30 or higher, applied generously and reapplied during prolonged outdoor exposure.
Tinted Sunscreen and Visible Light
Tinted sunscreens containing iron oxides may offer additional protection against visible light compared with untinted products. The American Academy of Dermatology recommends broad-spectrum, water-resistant SPF 30 or higher and practical measures such as hats, shade, and protective clothing. Tinted formulas can be especially useful when facial PIH is stubborn or when visible-light exposure is frequent.
Sunscreen does not erase existing pigment overnight. Its role is to prevent continued darkening and improve the likelihood that other treatments will work. A useful routine includes sunscreen every morning, even on days when outdoor exposure seems brief, because incidental exposure through windows, commuting, and errands can accumulate.
Topical Dermatologist Treatments for Stubborn PIH
Topical treatment should be selected according to skin type, pigment depth, sensitivity, pregnancy status, and the condition that caused the rash. Dermatologists often begin with one active ingredient at a time to limit irritation and make it easier to identify the source of a reaction.
Hydroquinone
Hydroquinone reduces melanin production by inhibiting tyrosinase, an enzyme involved in pigment synthesis. It remains a well-studied option for localized PIH, but dermatologists typically use it for a limited course and monitor the response. Prolonged unsupervised use can cause irritation and, rarely, ochronosis, a persistent blue-gray discoloration.
Availability and strength vary by country. In the United States, prescription hydroquinone is commonly used under medical supervision, while the regulatory status of nonprescription products has changed over time. A clinician should determine whether hydroquinone is appropriate, particularly for people with sensitive skin or a history of dermatitis.
Azelaic Acid
Azelaic acid helps reduce abnormal pigment production and also has anti-inflammatory properties. Dermatologists may recommend it when PIH follows acne, folliculitis, or dermatitis because it can address both discoloration and some inflammatory triggers. Common strengths range from approximately 10% in cosmetic products to 15% or 20% in prescription formulations.
Stinging, dryness, and irritation are possible, especially when the skin barrier is still damaged. A cautious approach is to apply a small amount several times per week, moisturize, and increase frequency only if the skin remains comfortable.
Retinoids
Topical retinoids, including adapalene, tretinoin, and related medicines, can encourage more even shedding of pigmented epidermal cells and may improve some causes of PIH. They are often useful when acne or follicular plugging continues to produce new marks. However, retinoids can initially cause dryness, peeling, and irritation, which may worsen PIH in reactive skin.
Dermatologists generally introduce retinoids slowly, use moisturizer, and avoid applying them to actively inflamed or broken skin. Retinoids are not appropriate during pregnancy unless a qualified clinician specifically advises otherwise; patients who are pregnant, trying to conceive, or breastfeeding should ask their healthcare professional about safer alternatives.
Other Physician-Guided Options
Cysteamine, kojic acid, vitamin C, and certain topical combinations may be considered for selected patients, although evidence and tolerability vary. Topical tranexamic acid is another option used by some dermatologists, often off-label, particularly when pigmentation has a melasma-like pattern. “Natural” does not mean risk-free: lemon juice, undiluted essential oils, abrasive scrubs, and unregulated bleaching creams can cause burns or dermatitis.
Procedures for Persistent Post-Rash Pigment
Chemical peels, microneedling, intense pulsed light, and laser treatments may improve selected cases, but procedures can also trigger more inflammation and darker pigmentation. The risk is particularly important for patients with Fitzpatrick skin types IV through VI or anyone who develops dark marks easily after minor injuries.
When Procedures May Be Appropriate
A dermatologist may consider a procedure when the original rash is fully controlled, the pigment has remained stable, and topical treatment has produced limited improvement. Conservative settings, test spots, strict sun protection, and experienced medical supervision are important. Procedures performed in nonmedical settings or with aggressive settings can worsen PIH and create scars.
A practical treatment timeline is gradual rather than immediate. Some superficial marks may begin to lighten over several months, while deeper dermal pigment can persist longer. New inflammation, repeated scratching, and inadequate sun protection commonly reset that timeline.
A Dermatologist-Informed Routine for Stubborn Pigment
A simple routine is often safer and more effective than combining multiple strong products. The following sequence reflects common dermatology principles, but it does not replace an individualized diagnosis:
First, identify and control the cause of the rash. Second, use a gentle, fragrance-free cleanser and a moisturizer that supports the skin barrier. Third, apply broad-spectrum SPF 30 or higher every morning, with a tinted product when visible-light protection is desired. Fourth, add one pigment-directed treatment gradually. Finally, stop or reduce the active ingredient if burning, swelling, blistering, or a new rash develops.
Avoid picking, scratching, harsh exfoliation, and unsupervised steroid-containing lightening creams. The World Health Organization has warned about the health risks associated with mercury-containing skin-lightening products, while dermatology organizations have repeatedly highlighted the risks of irritant and counterfeit products.
When to Seek Medical Evaluation
A medical evaluation is appropriate when pigmentation appears without a clear rash, changes rapidly, becomes raised or ulcerated, affects the eyes or mouth, follows a new medication, or is accompanied by pain, fever, blistering, or widespread peeling. A dermatologist can distinguish PIH from melasma, post-inflammatory erythema, lichen planus pigmentosus, drug-induced pigmentation, infection, and less common conditions.
People with recurrent rashes should also address triggers such as fragranced products, occupational exposures, allergens, friction, and uncontrolled eczema. Preventing new inflammation is as important as fading old marks.
Conclusion: Dermatologist Recommendations for Post-Inflammatory Hyperpigmentation
Post-inflammatory hyperpigmentation is residual pigment after skin inflammation, not simply a cosmetic stain. Dermatologists generally prioritize diagnosis and rash control, followed by daily broad-spectrum sunscreen, gentle barrier care, and a carefully selected topical such as azelaic acid, a retinoid, or medically supervised hydroquinone. Procedures can help selected patients but carry a meaningful risk of worsening pigment, especially in darker skin.
The most useful next step is to photograph the area in consistent lighting, stop irritating or unregulated products, and arrange a dermatology assessment if the mark is persistent, recurrent, or diagnostically uncertain. Reliable patient information from the American Academy of Dermatology, DermNet, and a qualified dermatologist can help guide a safer, evidence-based plan.
Sources: American Academy of Dermatology, How to fade dark spots in darker skin tones, https://www.aad.org/public/everyday-care/skin-care-secrets/routine/dark-spots; DermNet, Postinflammatory hyperpigmentation, https://dermnetnz.org/topics/postinflammatory-hyperpigmentation; American Academy of Dermatology, Sunscreen FAQs, https://www.aad.org/media/stats-sunscreen; World Health Organization, Mercury in skin lightening products, https://www.who.int/publications/i/item/9789240008407; StatPearls, Postinflammatory Hyperpigmentation, https://www.ncbi.nlm.nih.gov/books/NBK559150/
